MDR.AU · MedAdvisor Limited

-

Please sign in to comment on MDR.AU

1 Comment

Admin

4 years, 10 months ago

MedAdvisor Limited is currently in a long term downtrend where the price is trading 12.4% below its 200 day moving average.

From a valuation standpoint, the stock is 98.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.

MedAdvisor Limited's total revenue rose by 189.4% to $13M since the same quarter in the previous year.

Its net income has dropped by 47.8% to $-8M since the same quarter in the previous year.

Finally, its free cash flow grew by 54.9% to $-1M since the same quarter in the previous year.

Based on the above factors, MedAdvisor Limited gets an overall score of 3/5.

Exchange	AU
CurrencyCode	AUD
Sector	Healthcare
Industry	Health Information Services
ISIN	AU000000MDR6

Beta	1.03
Target Price	0.15
Market Cap	14M
PE Ratio	None
Dividend Yield	None

ABOUT

MedAdvisor Limited

Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anme to Adheris Health Limited in November 2025. The company was incorporated in 2010 and is based in Woburn, Massachusetts.

MDR.AU · MedAdvisor Limited

-

MedAdvisor Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest MedAdvisor Limited using a moving average strategy